Giannis Mountzios, Consultant Medical Oncologist of the 2nd Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, shared a post on X:
“A must-read Review on the ever-evolving field of EGFR mut NSCLC in Nature Review Clinical Oncology highlighting:
– Strategies to improve on 1L 3rd Gen TKI mono therapy
– Ways to tackle resistance post-Osi
– Perioperative landscape.”
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
Authors: Fei Zhou, Haoyue Guo, Yang Xia, Xiuning Le, Daniel S. W. Tan, Suresh S. Ramalingam, Caicun Zhou
